A critical review of the analytical approaches for circulating tumor biomarker kinetics during treatment
Almufti, R., Wilbaux, M., Oza, A., Henin, E., Freyer, G., Tod, M., Colomban, O., You, B.
Published in Annals of oncology (01.01.2014)
Published in Annals of oncology (01.01.2014)
Get full text
Journal Article
Predictive values of hCG clearance for risk of methotrexate resistance in low-risk gestational trophoblastic neoplasias
You, B., Pollet-Villard, M., Fronton, L., Labrousse, C., Schott, A.-M., Hajri, T., Girard, P., Freyer, G., Tod, M., Tranchand, B., Colomban, O., Ribba, B., Raudrant, D., Massardier, J., Chabaud, S., Golfier, F.
Published in Annals of oncology (01.08.2010)
Published in Annals of oncology (01.08.2010)
Get full text
Journal Article
1422P Validation of the prognostic value of the early modeled longitudinal PSA kinetics (KELIM and KPROD) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with taxanes in FIRSTANA
Carrot, A., Oudard, S., Colomban, O., Fizazi, K., Sartor, O., Freyer, G., You, B.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
634P Prognostic value of the modeled PSA kinetic parameter (KELIM) in prostate cancer patients with rising PSA after primary local therapy treated in a prospective phase III trial with ADT +/- docetaxel
Carrot, A., Elaidi, R-T., Colomban, O., Maillet, D., Tod, M., You, B., Oudard, S.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
792P Prognostic role of the modeled CA-125 KELIM in early FIGO stage I and II ovarian cancers (OC): A GCIG individual-patient data meta-analysis
Corbaux, P., You, B., Glasspool, R.M., Yanaihara, N., Tinker, A., Lindemann, K., Mirza, M.R., Ray-Coquard, I., Subtil, F., Colomban, O., Peron, J., Karamouza, E., McNeish, I., Kelly, C., Kagimura, T., Welch, S., Lewsley, L-A., Paoletti, X., Cook, A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
847P The prognostic value of chemosensitivity, estimated by the modeled CA-125 KELIM, in ovarian cancer patients treated with neo-adjuvant chemotherapy in the Netherlands
Van Wagensveld, L., Colomban, O., Van Der AA, M., Tod, M., Sonke, G.S., Kruitwagen, R., You, B.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
773P Role of tumor primary chemosensitivity assessed by modeled CA-125 KELIM to predict complete interval debulking surgery (IDS) in ovarian carcinoma patients treated with neo-adjuvant chemotherapy and immunotherapy: A GINEGEPS/GINECO study of the NeoPembrOv and INeOV trials
Corbaux, P., Leary, A., Le Saux, O., Colomban, O., Treilleux, I., Genestie, C., Chardin, L., Collet, L., Bengrine Lefevre, L., Auvray Kuentz, M., Martinez, M., Blonz, C., Priou, F., Alexandre, J., Cloarec, N., Lebreton, C., Venat, L., Savoye, A.M., You, B., Ray-Coquard, I.L.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
793P Strong relationships between the CA-125 KELIM score and the tumor biological effects after neo-adjuvant chemotherapy in advanced ovarian cancer patients: CHIVA trial (GINECO)
Catana, A.M., Just, P-A., De Rauglaudre, G., Raban, N., Chevalier, A., Ferron, G., Kaminsky-Forrett, M-C., Ray-Coquard, I.L., Hamizi, S., Combe, P-F., Abadie Lacourtoisie, S., Joly Lobbedez, F., Meunier, J., Lebreton, C., Alexandre, J., Follana, P., Lotz, J-P., Del Piano, F., Colomban, O., You, B.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
751P Survival prognostic and surrogate values of the early modeled CA-125 KELIM in newly diagnosed advanced ovarian cancer: Data from the GCIG meta-analysis group
Corbaux, P., You, B., Glasspool, R.M., Yanaihara, N., Tinker, A.V., Lindemann, K., Ray-Coquard, I.L., Mirza, M.R., Subtil, F., Colomban, O., Peron, J., Karamouza, E., McNeish, I., Hinsley, S., Kagimura, T., Welch, S., Lewsley, L-A., Paoletti, X., Cook, A.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
596P CA125 longitudinal decline kinetic is complementary to BRCA testing in first-line high grade serous ovarian carcinoma (HGSOC) patients (pts)
Becker, O., Chevrier, M., Gladieff, L., Joly Lobbedez, F., Ray-Coquard, I.L., Floquet, A., Pomel, C., Costaz, H., Pautier, P., De La Motte Rouge, T., Sabatier, R., Classe, J-M., Leblanc, E., Marchal, F., Colombo, P-E., Barranger, E., Colomban, O., Bosquet, L., You, B., Rodrigues, M.J.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
Preponderant impact of the chemosensitivity assessed by the modeled CA-125 kinetic parameter KELIM on the success of the first line treatment: Pooled analysis of AGO-OVAR 7, AGO-OVAR 9 and ICON7 trials--a GINECO-GINEGEPS study
You, B., Tod, M., Leary, A., Ray-Coquard, I., Lortholary, A., Hardy-Bessard, A.C., Perren, T., Cook, A., Pfisterer, J., Bois, A.D., Kurzeder, C., Burges, A., Peron, J., Freyer, G., Colomban, O.
Published in Gynecologic oncology (01.10.2020)
Published in Gynecologic oncology (01.10.2020)
Get full text
Journal Article
1027P - Early prediction of the platinum-resistant relapse risk using the CA125 modeled kinetic parameter KELIM: A pooled analysis of AGO-OVAR 7 & 9; ICON 7 (AGO/GINECO/ MRC CTU/GCIG trials)
Colomban, O., Tod, M., Leary, A., Ray-Coquard, I.L., Lortholary, A., Hardy-Bessard, A.-C., Pfisterer, J., Du Bois, A., Kurzeder, C., Burges, A., Peron, J., Freyer, G., You, B.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1027PEarly prediction of the platinum-resistant relapse risk using the CA125 modeled kinetic parameter KELIM: A pooled analysis of AGO-OVAR 7 & 9; ICON 7 (AGO/GINECO/ MRC CTU/GCIG trials)
Colomban, O, Tod, M, Leary, A, Ray-Coquard, I L, Lortholary, A, Hardy-Bessard, A-C, Pfisterer, J, Du Bois, A, Kurzeder, C, Burges, A, Peron, J, Freyer, G, You, B
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Early prediction of the platinum-resistant relapse risk using the CA125 modeled kinetic parameter KELIM: A pooled analysis of AGO-OVAR 7 & 9; ICON 7 (AGO/GINECO/ MRC CTU/GCIG trials)
Colomban, O., Tod, M., Leary, A., Ray-Coquard, I.L., Lortholary, A., Hardy-Bessard, A.-C., Pfisterer, J., Du Bois, A., Kurzeder, C., Burges, A., Peron, J., Freyer, G., You, B.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
815MO The impact of chemosensitivity assessed by modeled CA-125 KELIM on the likelihood of long progression-free survivorship (PS) after 1st line treatment in ovarian cancer: An analysis of 4,450 patients
You, B., Van Wagensveld, L., Tod, M., Sonke, G.S., Kruitwagen, R., du Bois, A., Selle, F., Perren, T.J., Pfisterer, J., Joly, F., Cook, A., Kaminsky-Forrett, M-C., Wollschlaeger, K., Lortholary, A., Tome, O., Leary, A., Freyer, G., Van Der AA, M., Colomban, O.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
1032 Strong association between pathological response to neoadjuvant chemotherapy, TILs and modeled CA125 KELIM in ovarian carcinomas: CHIVA trial, GINECO
Pierre-Alexandre, J, Moret, S, Colomban, O, Combe, P, Abadie-Lacourtoisie, S, Meunier, J, Floquet, A, Venat-Bouvet, L, Louvet, C, Favier, L, Follana, P, Lotz, JP, Del Piano, F, Leheurteur, M, Alliot, CR, De Rauglaudre, G, Raban, N, Chevalier-Place, A, Leary, A, You, B
Published in International journal of gynecological cancer (12.10.2021)
Published in International journal of gynecological cancer (12.10.2021)
Get full text
Journal Article
Comparison of 11 circulating miRNAs and CA125 kinetics in ovarian cancer during first line treatment: Data from the randomized CHIVA trial (a GINECO-GCIG study)
Robelin, P., Tod, M., Colomban, O., Ray-Coquard, I.L., De Rauglaudre, G., Florence, J., Chevalier, A., combe, P., Lortholary, A., Hamizi, S., Raban, N., Ferron, G., Meunier, J., Berton-Rigaud, D., Alexandre, J., Kaminsky-Forrett, M.-C., Dubot, C., Leary, A., Malaurie, E., You, B.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1037P - Post-hoc analysis of the nintedanib exposure-response relationships in the CHIVA trial in advanced ovarian cancer: A GINECO study
Haviari, S., Blanchet, B., Colomban, O., Venat-Bouvet, L., Dohollou, N., Floquet, A., Louvet, C., Lotz, J.-P., Lacourtoisie, S Abadie, Favier, L., Fabbro, M., Bonichon-Lamichhane, N., Kurtz, J.E., Follana, P., Leheurteur, M., Del Piano, F., Alliot, C.R., Alexandre, J., You, B., Tod, M.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1945PComparison of 11 circulating miRNAs and CA125 kinetics in ovarian cancer during first line treatment: Data from the randomized CHIVA trial (a GINECO-GCIG study)
Robelin, P, Tod, M, Colomban, O, Ray-Coquard, I L, De Rauglaudre, G, Florence, J, Chevalier, A, combe, P, Lortholary, A, Hamizi, S, Raban, N, Ferron, G, Meunier, J, Berton-Rigaud, D, Alexandre, J, Kaminsky-Forrett, M-C, Dubot, C, Leary, A, Malaurie, E, You, B
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article